HDAC4 inhibitors
1 paper studies it
Across all fields, 1 paper: none in people yet, 1 review
Latest
Oxidative Medicine and Cellular Longevity
HDAC4 Inhibitors as Antivascular Senescence Therapeutics
ReviewInterventions
1 paper studies it
Across all fields, 1 paper: none in people yet, 1 review